226 results on '"Deverka, Patricia A."'
Search Results
2. Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access
3. Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing–Based Tests: Challenges, Opportunities, and Potential Solutions
4. Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions
5. Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?
6. Insurance coverage for genomic tests
7. Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research
8. Payer coverage policies for multigene tests
9. Payer decision making for next-generation sequencing–based genetic tests: insights from cell-free DNA prenatal screening
10. Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.
11. EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS
12. Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies
13. Genomic medicine year in review: 2023
14. A review of economic issues for gene‐targeted therapies: Value, affordability, and access
15. Payer reimbursement practices and incentives for improving interpretation of germline genetic testing.
16. Genomic Medicine Year in Review: 2022
17. Report – Cost and Clinical Utility of WES and WGS in pediatric patients with suspected genetic disease
18. Supplemental Files for Payer Incentives for Improving Interpretation of Germline Genetic Testing
19. A Structured Approach to Prioritizing Cancer Research Using Stakeholders and Value of Information
20. A research agenda to support the development and implementation of genomics-based clinical informatics tools and resources
21. Prioritization in Comparative Effectiveness Research: The CANCERGEN Experience
22. Genomic medicine year in review: 2021
23. A review of economic issues for gene‐targetedtherapies: Value, affordability, and access
24. Overcoming the Reimbursement Barriers for Clinical Sequencing
25. Association of Breast Cancer Screening Behaviors With Stage at Breast Cancer Diagnosis and Potential for Additive Multi-Cancer Detection via Liquid Biopsy Screening: A Claims-Based Study
26. Utilizing commercial health insurance claims data to identify the impact of cancer screening and estimate the added benefit of a multicancer liquid biopsy ordered during routine physical exams.
27. Non-indication based genetic testing in the workplace: a qualitative cross-case comparison of genetic testing vendors
28. Clinical integration of next generation sequencing: coverage and reimbursement challenges
29. Patient Receipt and Understanding of Written Information Provided with Isotretinoin and Estrogen Prescriptions
30. Genomic Medicine Year in Review: 2020
31. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children
32. The effect of incentive-based formularies on prescription-drug utilization and spending
33. Stakeholder engagement in comparative effectiveness research: how will we measure success?
34. Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement
35. Genetic testing and employer‐sponsored wellness programs: An overview of current vendors, products, and practices
36. Genomic Medicine Year in Review: 2019
37. Institutional Profile: UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care
38. From Genome to Drug
39. The Effect of Three-Tier Formulary Adoption on Medication Continuation and Spending among Elderly Retirees
40. Response to Concerns Regarding the ISPOR Code of Ethics for Researchers
41. ISPOR Code of Ethics for Researchers Background Article—Report of the ISPOR Task Force on Code of Ethics for Researchers
42. Opportunities, resources, and techniques for implementing genomics in clinical care
43. The Role of Participants in a Medical Information Commons
44. Characterizing the Biomedical Data-Sharing Landscape
45. Hopeful and Concerned: Public Input on Building a Trustworthy Medical Information Commons
46. Importance of Participant-Centricity and Trust for a Sustainable Medical Information Commons
47. Health care utilization and behavior changes after workplace genetic testing at a large US health care system
48. A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies
49. Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects
50. Pharmacoeconomics: Identifying the Issues Overview and Advisory Panel Report Summary
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.